The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 353:2712-2713 December 22, 2005 Number 25
NextNext

Immunosuppression, Skin Cancer, and Ultraviolet A Radiation
John A. Parrish, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Skin cancer is a serious problem in immunosuppressed patients. In these patients, cutaneous cancers are common in areas of the skin that are exposed to the sun, are more aggressive than in patients who are not immunosuppressed, are sometimes fatal, and often require multiple surgical procedures.1 Although the absolute risk of squamous-cell carcinoma after renal transplantation is highest in sunny climates, the risk of these tumors is also greatly elevated in less sunny areas. For example, a study of more than 700 renal-transplant recipients in the Netherlands disclosed that the overall incidence of squamous-cell carcinoma was 250 times that in . . . [Full Text of this Article]


Source Information

From the Department of Dermatology, Massachusetts General Hospital, Boston.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.